Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion

What happened: Bruker said it expects FY 2026 non-GAAP EPS of $2.10 to $2.15 and is targeting 250 to 300 bps of operating margin expansion. Management also reported a fifth consecutive quarter of BSI book-to-bill above 1. Key numbers: FY 2026 non-GAAP EPS guidance $2.10 to $2.15; operating margin expansion target 250 to 300 bps; BSI book-to-bill above 1 for a fifth consecutive quarter. Why it matters: The guidance pairs earnings expectations with a margin expansion target, while continued bookings strength in Bruker Scientific Instruments points to sustained order momentum.

Bruker said it expects FY 2026 non-GAAP EPS of $2.10 to $2.15 and is targeting 250 to 300 bps of operating margin expansion. Management also reported a fifth consecutive quarter of BSI book-to-bill above 1.

The guidance pairs earnings expectations with a margin expansion target, while continued bookings strength in Bruker Scientific Instruments points to sustained order momentum.